OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
Monika Lejman, Kinga Kuśmierczuk, Kinga Bednarz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9827-9827
Open Access | Times Cited: 27
Monika Lejman, Kinga Kuśmierczuk, Kinga Bednarz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9827-9827
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial
Myriam Campbell, Csongor Kiss, Martin Zimmermann, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 19, pp. 3499-3511
Closed Access | Times Cited: 46
Myriam Campbell, Csongor Kiss, Martin Zimmermann, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 19, pp. 3499-3511
Closed Access | Times Cited: 46
Pediatric Acute Lymphoblastic Leukemia Emerging Therapies—From Pathway to Target
Anca Ivanov, Mirabela Alecsa, Roxana Popescu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4661-4661
Open Access | Times Cited: 17
Anca Ivanov, Mirabela Alecsa, Roxana Popescu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4661-4661
Open Access | Times Cited: 17
A Review of Acute Lymphocytic Leukemia (ALL) in the Pediatric Population: Evaluating Current Trends and Changes in Guidelines in the Past Decade
Queen L Ekpa, Prince C Akahara, Alexis M Anderson, et al.
Cureus (2023)
Open Access | Times Cited: 14
Queen L Ekpa, Prince C Akahara, Alexis M Anderson, et al.
Cureus (2023)
Open Access | Times Cited: 14
Changes in Symptom Clusters Over the Course of Chemotherapy in Children With Acute Lymphoblastic Leukemia: A Longitudinal Survey
Xi Wang, Manyu Zhang, J. Liu, et al.
Journal of Pediatric Health Care (2025)
Closed Access
Xi Wang, Manyu Zhang, J. Liu, et al.
Journal of Pediatric Health Care (2025)
Closed Access
Improving data interpretability with new differential sample variance gene set tests
Yasir Rahmatallah, Galina Glazko
BMC Bioinformatics (2025) Vol. 26, Iss. 1
Open Access
Yasir Rahmatallah, Galina Glazko
BMC Bioinformatics (2025) Vol. 26, Iss. 1
Open Access
Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia
Katarzyna Pawińska-Wąsikowska, Aleksandra Wieczorek, Walentyna Balwierz, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 458-458
Open Access | Times Cited: 17
Katarzyna Pawińska-Wąsikowska, Aleksandra Wieczorek, Walentyna Balwierz, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 458-458
Open Access | Times Cited: 17
Oral Manifestations: A Warning-Sign in Children with Hematological Disease Acute Lymphocytic Leukemia
Sandra Clara Soares, L. Roux, Ana Rita Castro, et al.
Hematology Reports (2023) Vol. 15, Iss. 3, pp. 491-502
Open Access | Times Cited: 9
Sandra Clara Soares, L. Roux, Ana Rita Castro, et al.
Hematology Reports (2023) Vol. 15, Iss. 3, pp. 491-502
Open Access | Times Cited: 9
Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era
Shang Mengxuan, Fen Zhou, Runming Jin
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 13
Shang Mengxuan, Fen Zhou, Runming Jin
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 13
Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas
Ioannis Kyriakidis, Elpis Mantadakis, Eftichia Stiakaki, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5022-5022
Open Access | Times Cited: 13
Ioannis Kyriakidis, Elpis Mantadakis, Eftichia Stiakaki, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5022-5022
Open Access | Times Cited: 13
Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies
Faryal Munir, Jiasen He, Jeremy Connors, et al.
Translational Pediatrics (2023) Vol. 12, Iss. 3, pp. 487-502
Open Access | Times Cited: 6
Faryal Munir, Jiasen He, Jeremy Connors, et al.
Translational Pediatrics (2023) Vol. 12, Iss. 3, pp. 487-502
Open Access | Times Cited: 6
Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL)
Zakaria Yahya Khawaji, Nussaiba Yahya Khawaji, Mohammed Abdullah Alahmadi, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 9, pp. 1163-1183
Closed Access | Times Cited: 1
Zakaria Yahya Khawaji, Nussaiba Yahya Khawaji, Mohammed Abdullah Alahmadi, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 9, pp. 1163-1183
Closed Access | Times Cited: 1
The role of GATA4 in mesenchymal stem cell senescence: A new frontier in regenerative medicine
M. Arockia Babu, Renuka Jyothi S, Irwanjot Kaur, et al.
Regenerative Therapy (2024) Vol. 28, pp. 214-226
Closed Access | Times Cited: 1
M. Arockia Babu, Renuka Jyothi S, Irwanjot Kaur, et al.
Regenerative Therapy (2024) Vol. 28, pp. 214-226
Closed Access | Times Cited: 1
Research on the Targeted Treatment of Squamous Cell Carcinoma by Nanographene Drug Delivery System
Xiangyu Zhang, Liwei Guo, Zhenbang Sun, et al.
Advances in Materials Science and Engineering (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 3
Xiangyu Zhang, Liwei Guo, Zhenbang Sun, et al.
Advances in Materials Science and Engineering (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 3
Dental dilemmas in blood disorders: Navigating oral health in hematological diseases
María Concepción Treviño-Tijerina, Julia Garza-Villarreal, Sara Sáenz-Rangel, et al.
International Journal of Applied Dental Sciences (2023) Vol. 9, Iss. 4, pp. 283-289
Open Access | Times Cited: 3
María Concepción Treviño-Tijerina, Julia Garza-Villarreal, Sara Sáenz-Rangel, et al.
International Journal of Applied Dental Sciences (2023) Vol. 9, Iss. 4, pp. 283-289
Open Access | Times Cited: 3
Prognostic Value of Immunotyping Combined with Targeted Therapy in Patients with Non-Small-Cell Lung Cancer and Establishment of Nomogram Model
Sha Tian, Yinmei Guo, Jiajun Fu, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 4
Sha Tian, Yinmei Guo, Jiajun Fu, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 4
Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms
Emma C. Bernsen, Valery J. Hogenes, Bastiaan Nuijen, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2834-2834
Open Access | Times Cited: 3
Emma C. Bernsen, Valery J. Hogenes, Bastiaan Nuijen, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2834-2834
Open Access | Times Cited: 3
Antibody-Drug Conjugate in the Treatment of Pediatric AML and ALL: A Review
Zhe Liu, Liyan Fan, X H Fan, et al.
International Journal of Clinical and Experimental Medical Sciences (2024)
Open Access
Zhe Liu, Liyan Fan, X H Fan, et al.
International Journal of Clinical and Experimental Medical Sciences (2024)
Open Access
Prevalence and Treatment Outcomes of Childhood Acute Lymphoblastic Leukemia in Kosovo
Flaka Pasha, Dunja Urbančič, Rufadie Maxhuni, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1988-1988
Open Access
Flaka Pasha, Dunja Urbančič, Rufadie Maxhuni, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1988-1988
Open Access
Blinatumomab in pediatric acute lymphoblastic leukemia: one center experience
N. V. Muliarova, А. Yu. Smirnova, S. I. Lapaeva, et al.
Russian Journal for Personalized Medicine (2024) Vol. 4, Iss. 2, pp. 156-169
Open Access
N. V. Muliarova, А. Yu. Smirnova, S. I. Lapaeva, et al.
Russian Journal for Personalized Medicine (2024) Vol. 4, Iss. 2, pp. 156-169
Open Access
A Second Wind for Inorganic APIs: Leishmanicidal and Antileukemic Activity of Hydrated Bismuth Oxide Nanoparticles
Andriy Grafov, Ana Flávia da Silva Chagas, Alice de Freitas Gomes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 874-874
Open Access
Andriy Grafov, Ana Flávia da Silva Chagas, Alice de Freitas Gomes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 874-874
Open Access
The Emergence of a Novel Anti-Neoplastic Era in Gene Therapy for Cancer: A Review Study
Alaa Ramthan Hussein, Ali Mohammed Hussein, Sarmad Qassim Mohammad
European Journal of Theoretical and Applied Sciences (2024) Vol. 2, Iss. 4, pp. 523-537
Closed Access
Alaa Ramthan Hussein, Ali Mohammed Hussein, Sarmad Qassim Mohammad
European Journal of Theoretical and Applied Sciences (2024) Vol. 2, Iss. 4, pp. 523-537
Closed Access
Association of FOXO3 (rs17069665) gene polymorphism and childhood acute lymphoblastic leukemia in Egypt
Dalia Mohamed Abd El Hassib, Magda Abd el-Aziz Zidan, Samar Mahmoud Elbahy, et al.
Gene Reports (2024) Vol. 37, pp. 102015-102015
Closed Access
Dalia Mohamed Abd El Hassib, Magda Abd el-Aziz Zidan, Samar Mahmoud Elbahy, et al.
Gene Reports (2024) Vol. 37, pp. 102015-102015
Closed Access
Improving data interpretability with new differential sample variance gene set tests
Yasir Rahmatallah, Galina Glazko
Research Square (Research Square) (2024)
Closed Access
Yasir Rahmatallah, Galina Glazko
Research Square (Research Square) (2024)
Closed Access
Architecting lymphoma fusion: PROMETHEE-II guided optimization of combination therapeutic synergy
Syed Anas Ansar, Swati Arya, Nupur Soni, et al.
International Journal of Information Technology (2024)
Closed Access
Syed Anas Ansar, Swati Arya, Nupur Soni, et al.
International Journal of Information Technology (2024)
Closed Access
Genetic Susceptibility and Treatment Personalization in Acute Lymphoblastic Leukemia: A Comprehensive Review of Genetic Susceptibility and Targeted Therapies
Nikita Nirmalkar, Ishani Arora, Vaishnavi Mishra, et al.
Journal of Applied Hematology (2024) Vol. 15, Iss. 3, pp. 163-168
Open Access
Nikita Nirmalkar, Ishani Arora, Vaishnavi Mishra, et al.
Journal of Applied Hematology (2024) Vol. 15, Iss. 3, pp. 163-168
Open Access
